Brigitte Montès

2.7k total citations
39 papers, 1.0k citations indexed

About

Brigitte Montès is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Brigitte Montès has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 25 papers in Virology and 13 papers in Epidemiology. Recurrent topics in Brigitte Montès's work include HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (11 papers). Brigitte Montès is often cited by papers focused on HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (11 papers). Brigitte Montès collaborates with scholars based in France, Spain and United States. Brigitte Montès's co-authors include Jacques Reynes, Michel Segondy, Éric Delaporte, Martine Peeters, Gilles Peytavin, Anne‐Geneviève Marcelin, Marc Wirden, Vincent Cálvez, Jacques Izopet and Christine Katlama and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and AIDS.

In The Last Decade

Brigitte Montès

37 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Montès France 16 884 795 200 168 47 39 1.0k
Margrit Carlson United States 8 311 0.4× 296 0.4× 177 0.9× 76 0.5× 52 1.1× 15 537
Michel P. de Baar Netherlands 12 325 0.4× 292 0.4× 105 0.5× 119 0.7× 39 0.8× 16 511
María Teresa Cuevas Spain 19 574 0.6× 600 0.8× 353 1.8× 142 0.8× 52 1.1× 44 898
Pauline Campa France 16 592 0.7× 637 0.8× 274 1.4× 65 0.4× 104 2.2× 28 914
Laurence Bocket France 13 339 0.4× 304 0.4× 144 0.7× 50 0.3× 82 1.7× 58 558
Lavinia Fabeni Italy 15 443 0.5× 377 0.5× 152 0.8× 125 0.7× 74 1.6× 58 599
Katharine J. Bar United States 16 470 0.5× 535 0.7× 188 0.9× 83 0.5× 52 1.1× 53 750
Lina Josefsson Sweden 7 284 0.3× 421 0.5× 136 0.7× 122 0.7× 16 0.3× 7 614
Valeria Cento Italy 18 524 0.6× 226 0.3× 509 2.5× 95 0.6× 431 9.2× 57 916
Randall Lanier United States 16 347 0.4× 467 0.6× 452 2.3× 259 1.5× 27 0.6× 31 814

Countries citing papers authored by Brigitte Montès

Since Specialization
Citations

This map shows the geographic impact of Brigitte Montès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Montès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Montès more than expected).

Fields of papers citing papers by Brigitte Montès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Montès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Montès. The network helps show where Brigitte Montès may publish in the future.

Co-authorship network of co-authors of Brigitte Montès

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Montès. A scholar is included among the top collaborators of Brigitte Montès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Montès. Brigitte Montès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
André‐Garnier, Elisabeth, Laurence Bocket, Thomas Bourlet, et al.. (2024). Use of genotypic HIV DNA testing: a DELPHI-type consensus. Journal of Antimicrobial Chemotherapy. 79(3). 578–588. 3 indexed citations
3.
Foulongne, Vincent, Didier Laureillard, Nicolas Nagot, et al.. (2021). Détection de mutations de résistance du VIH aux antirétroviraux : vers un dépistage rapide pré-thérapeutique ?. Transfusion Clinique et Biologique. 28(4). S106–S107.
4.
Bolloré, Karine, Amandine Pisoni, Anne‐Sophie Bedin, et al.. (2021). Diagnosis value of SARS‐CoV‐2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission. Journal of Medical Virology. 93(5). 3069–3076. 26 indexed citations
5.
Charpentier, Charlotte, et al.. (2017). HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study. Journal of Antimicrobial Chemotherapy. 72(10). 2831–2836. 33 indexed citations
6.
Masquelier, Bruno, Cathia Soulié, Constance Delaugerre, et al.. (2012). Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice. Journal of Antimicrobial Chemotherapy. 67(10). 2487–2493. 5 indexed citations
7.
Grotto, Rejane Maria Tommasini, et al.. (2010). Variability of the conserved V3 loop tip motif in HIV-1 subtype B isolates collected from Brazilian and French patients. Brazilian Journal of Microbiology. 41(3). 720–728. 3 indexed citations
8.
9.
Mendoza, Carmen de, Marco Koppelman, Brigitte Montès, et al.. (2005). Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. Journal of Virological Methods. 127(1). 54–59. 36 indexed citations
10.
Montès, Brigitte, Laurence Vergne, Martine Peeters, et al.. (2004). Comparison of Drug Resistance Mutations and Their Interpretation in Patients Infected With Non-B HIV-1 Variants and Matched Patients Infected With HIV-1 Subtype B. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(4). 329–336. 32 indexed citations
11.
Masquelier, Bernard, Catherine Tamalet, Brigitte Montès, et al.. (2004). Genotypic Determinants of the Virological Response to Tenofovir Disoproxil Fumarate in Nucleoside Reverse Transcriptase Inhibitor-Experienced Patients. Antiviral Therapy. 9(3). 315–323. 30 indexed citations
12.
Montès, Brigitte & Michel Segondy. (2002). Prevalence of the mutational pattern E44D/A and/or V118I in the reverse transcriptase (RT) gene of HIV‐1 in relation to treatment with nucleoside analogue RT inhibitors. Journal of Medical Virology. 66(3). 299–303. 17 indexed citations
13.
Vergne, Laurence, Brigitte Montès, Martine Peeters, et al.. (2001). Patterns of Resistance Mutations to Antiretroviral Drugs in Extensively Treated HIV-1–Infected Patients With Failure of Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(1). 36–43. 54 indexed citations
14.
Pellegrin, Isabelle, Jacques Izopet, Jacques Reynes, et al.. (1999). Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. AIDS. 13(13). 1705–1709. 100 indexed citations
15.
16.
Reynes, Jacques, et al.. (1997). [Once-daily administration of didanosine in combination with anti-retroviral zidovudine in previously untreated patients].. PubMed. 45(5). 441–4. 2 indexed citations
17.
Coste, Joliette, Brigitte Montès, Jacques Reynes, et al.. (1996). Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. Journal of Medical Virology. 50(4). 293–302. 93 indexed citations
18.
Reynes, Jacques, Brigitte Montès, N. Atoui, & Michel Segondy. (1996). Significance of cytomegalovirus (CMV)‐pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus‐infected patients. Journal of Medical Virology. 49(3). 195–198. 10 indexed citations
19.
Montès, Brigitte, et al.. (1993). Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial. European Journal of Clinical Pharmacology. 45(2). 169–172. 6 indexed citations
20.
Bastide, M., et al.. (1989). [In vitro effect of itraconazole against various species of Candida].. PubMed. 37(5 Pt 2). 694–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margrit Carlson Breakdown of academic impact, for papers by Michel P. de Baar Breakdown of academic impact, for papers by María Teresa Cuevas Breakdown of academic impact, for papers by Pauline Campa Breakdown of academic impact, for papers by Laurence Bocket Breakdown of academic impact, for papers by Lavinia Fabeni Breakdown of academic impact, for papers by Katharine J. Bar Breakdown of academic impact, for papers by Lina Josefsson Breakdown of academic impact, for papers by Valeria Cento Breakdown of academic impact, for papers by Randall Lanier
Rankless by CCL
2026